PI
PRME icon

PEAK6 Investments’s Prime Medicine PRME Stock Holding History

PEAK6 Investments’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$174K Buy
45,013
+11,013
+32% +$51K ﹤0.01% 2823
2024
Q2 		$175K Buy
34,000
+17,000
+100% +$103K ﹤0.01% 2817
2024
Q1 		$119K Sell
17,000
-5,000
-23% -$37.9K ﹤0.01% 3305
2023
Q4 		$195K Buy
+22,000
New +$169K ﹤0.01% 3266

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PEAK6 Investments's PRME Position: Q3 2024 in Review

PEAK6 Investments increased its Prime Medicine (PRME) stake by 32% in Q3 2024, buying an estimated $51K and bringing the position to 45,013 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #2823.

PEAK6 Investments first reported a position in PRME in Q4 2023 and has held it in 4 quarters since. The position peaked at $195K in Q4 2023. 116 funds tracked by Wall St. Rank hold PRME as of Q3 2024.

  • PEAK6 Investments held 45,013 shares of Prime Medicine worth $174K as of Q3 2024.
  • PEAK6 Investments bought 11,013 Prime Medicine shares in Q3 2024, an estimated $51K.
  • Prime Medicine made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2823 holding.
  • PEAK6 Investments first reported a position in Prime Medicine in Q4 2023 and has held it in 4 quarters since.
  • PEAK6 Investments's Prime Medicine position peaked at $195K in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.